Federated Hermes’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Sell |
9,239
-202
| -2% | -$25.4K | ﹤0.01% | 1092 |
|
2025
Q1 | $1.04M | Sell |
9,441
-25,402
| -73% | -$2.81M | ﹤0.01% | 1089 |
|
2024
Q4 | $4.76M | Sell |
34,843
-54,079
| -61% | -$7.38M | 0.01% | 726 |
|
2024
Q3 | $10.2M | Sell |
88,922
-22,133
| -20% | -$2.55M | 0.02% | 568 |
|
2024
Q2 | $15.3M | Buy |
111,055
+3,818
| +4% | +$526K | 0.04% | 458 |
|
2024
Q1 | $14.8M | Sell |
107,237
-1,340
| -1% | -$185K | 0.03% | 481 |
|
2023
Q4 | $14.3M | Sell |
108,577
-1,685
| -2% | -$222K | 0.04% | 471 |
|
2023
Q3 | $12.4M | Buy |
110,262
+12,815
| +13% | +$1.44M | 0.03% | 483 |
|
2023
Q2 | $9.19M | Buy |
97,447
+16,986
| +21% | +$1.6M | 0.02% | 560 |
|
2023
Q1 | $8.14M | Buy |
80,461
+43,249
| +116% | +$4.38M | 0.02% | 595 |
|
2022
Q4 | $4.44M | Buy |
37,212
+22,066
| +146% | +$2.64M | 0.01% | 707 |
|
2022
Q3 | $1.61M | Sell |
15,146
-1,695
| -10% | -$180K | ﹤0.01% | 979 |
|
2022
Q2 | $1.64M | Sell |
16,841
-16,269
| -49% | -$1.59M | ﹤0.01% | 985 |
|
2022
Q1 | $3.1M | Sell |
33,110
-4,570
| -12% | -$428K | 0.01% | 902 |
|
2021
Q4 | $3.21M | Sell |
37,680
-1,975
| -5% | -$168K | 0.01% | 939 |
|
2021
Q3 | $3.8M | Sell |
39,655
-23,890
| -38% | -$2.29M | 0.01% | 888 |
|
2021
Q2 | $6.18M | Sell |
63,545
-86,225
| -58% | -$8.39M | 0.01% | 785 |
|
2021
Q1 | $14.6M | Buy |
149,770
+149,720
| +299,440% | +$14.6M | 0.03% | 568 |
|
2020
Q4 | $5K | Sell |
50
-89,533
| -100% | -$8.95M | ﹤0.01% | 2056 |
|
2020
Q3 | $8.61M | Buy |
89,583
+40,651
| +83% | +$3.91M | 0.02% | 601 |
|
2020
Q2 | $5.97M | Buy |
48,932
+22,432
| +85% | +$2.74M | 0.01% | 667 |
|
2020
Q1 | $2.29M | Sell |
26,500
-6,058
| -19% | -$524K | 0.01% | 848 |
|
2019
Q4 | $3.5M | Buy |
32,558
+24,047
| +283% | +$2.59M | 0.01% | 870 |
|
2019
Q3 | $767K | Sell |
8,511
-642
| -7% | -$57.9K | ﹤0.01% | 1358 |
|
2019
Q2 | $773K | Sell |
9,153
-677
| -7% | -$57.2K | ﹤0.01% | 1356 |
|
2019
Q1 | $866K | Sell |
9,830
-115,670
| -92% | -$10.2M | ﹤0.01% | 1342 |
|
2018
Q4 | $8.96M | Sell |
125,500
-26,988
| -18% | -$1.93M | 0.02% | 534 |
|
2018
Q3 | $18.7M | Buy |
152,488
+72,224
| +90% | +$8.88M | 0.04% | 373 |
|
2018
Q2 | $7.89M | Sell |
80,264
-65,789
| -45% | -$6.46M | 0.02% | 540 |
|
2018
Q1 | $12.1M | Buy |
146,053
+16,392
| +13% | +$1.36M | 0.04% | 377 |
|
2017
Q4 | $10.1M | Buy |
129,661
+5,007
| +4% | +$388K | 0.03% | 429 |
|
2017
Q3 | $7.64M | Buy |
124,654
+1,097
| +0.9% | +$67.2K | 0.02% | 458 |
|
2017
Q2 | $5.68M | Buy |
+123,557
| New | +$5.68M | 0.02% | 537 |
|
2016
Q1 | – | Sell |
-1,958
| Closed | -$111K | – | 2148 |
|
2015
Q4 | $111K | Sell |
1,958
-11,816
| -86% | -$670K | ﹤0.01% | 1558 |
|
2015
Q3 | $548K | Sell |
13,774
-2,174
| -14% | -$86.5K | ﹤0.01% | 1257 |
|
2015
Q2 | $762K | Buy |
15,948
+5,948
| +59% | +$284K | ﹤0.01% | 1232 |
|
2015
Q1 | $397K | Buy |
+10,000
| New | +$397K | ﹤0.01% | 1417 |
|